001     119229
005     20240228145428.0
024 7 _ |a 10.1038/ng.3722
|2 doi
024 7 _ |a pmid:27869826
|2 pmid
024 7 _ |a 1061-4036
|2 ISSN
024 7 _ |a 1546-1718
|2 ISSN
024 7 _ |a altmetric:13869679
|2 altmetric
037 _ _ |a DKFZ-2017-00019
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Weischenfeldt, Joachim
|b 0
245 _ _ |a Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.
260 _ _ |a New York, NY
|c 2017
|b Nature America
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1533719447_22870
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Extensive prior research focused on somatic copy-number alterations (SCNAs) affecting cancer genes, yet the extent to which recurrent SCNAs exert their influence through rearrangement of cis-regulatory elements (CREs) remains unclear. Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs). Analysis of 7,416 cancer genomes uncovered several pan-cancer candidate genes, including IRS4, SMARCA1 and TERT. We demonstrate that IRS4 overexpression in lung cancer is associated with recurrent deletions in cis, and we present evidence supporting a tumor-promoting role. We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer. Recurrent tandem duplications intersecting with a TAD boundary mediate de novo formation of a 3D contact domain comprising IGF2 and a lineage-specific super-enhancer, resulting in high-level gene activation. Our framework enables systematic inference of CRE rearrangements mediating dysregulation in cancer.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Dubash, Taronish Dorab
|0 P:(DE-He78)fd92a33f8a02f962db52bf8daa1b1dbf
|b 1
|u dkfz
700 1 _ |a Drainas, Alexandros P
|0 0000-0001-9081-9850
|b 2
700 1 _ |a Mardin, Balca R
|b 3
700 1 _ |a Chen, Yuanyuan
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Stütz, Adrian M
|b 5
700 1 _ |a Waszak, Sebastian M
|0 0000-0003-3042-9521
|b 6
700 1 _ |a Bosco, Graziella
|b 7
700 1 _ |a Halvorsen, Ann Rita
|b 8
700 1 _ |a Raeder, Benjamin
|0 0000-0002-9494-8884
|b 9
700 1 _ |a Efthymiopoulos, Theocharis
|b 10
700 1 _ |a Erkek, Serap
|0 P:(DE-He78)df8660bc5aba525f7fb6dba4aac15c1c
|b 11
700 1 _ |a Siegl, Christine
|0 P:(DE-He78)be98d27bcd782f4e5961b646107dc14b
|b 12
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 13
700 1 _ |a Brustugun, Odd Terje
|b 14
700 1 _ |a Dieter, Sebastian
|0 P:(DE-He78)34c336827b750ba10a020fd62ec4664f
|b 15
700 1 _ |a Northcott, Paul A
|b 16
700 1 _ |a Petersen, Iver
|b 17
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 18
700 1 _ |a Schneider, Martin
|b 19
700 1 _ |a Solberg, Steinar K
|b 20
700 1 _ |a Thunissen, Erik
|b 21
700 1 _ |a Weichert, Wilko
|b 22
700 1 _ |a Zichner, Thomas
|b 23
700 1 _ |a Thomas, Roman
|b 24
700 1 _ |a Peifer, Martin
|b 25
700 1 _ |a Helland, Aslaug
|b 26
700 1 _ |a Ball, Claudia
|0 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce
|b 27
700 1 _ |a Jechlinger, Martin
|b 28
700 1 _ |a Sotillo, Rocio
|0 P:(DE-HGF)0
|b 29
700 1 _ |a Glimm, Hanno
|0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
|b 30
700 1 _ |a Korbel, Jan O
|0 0000-0002-2798-3794
|b 31
773 _ _ |a 10.1038/ng.3722
|g Vol. 49, no. 1, p. 65 - 74
|0 PERI:(DE-600)1494946-5
|n 1
|p 65 - 74
|t Nature genetics
|v 49
|y 2017
|x 1546-1718
909 C O |p VDB
|o oai:inrepo02.dkfz.de:119229
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)fd92a33f8a02f962db52bf8daa1b1dbf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)df8660bc5aba525f7fb6dba4aac15c1c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)be98d27bcd782f4e5961b646107dc14b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)34c336827b750ba10a020fd62ec4664f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT GENET : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT GENET : 2015
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l Klinische Epidemiologie und Alternsforschung
|x 0
920 1 _ |0 I:(DE-He78)G110-20160331
|k G110
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 2
920 1 _ |0 I:(DE-He78)B220-20160331
|k B220
|l Molekulare Grundlagen thorakaler Tumoren
|x 3
920 1 _ |0 I:(DE-He78)G100-20160331
|k G100
|l Translationale Onkologie
|x 4
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 5
920 1 _ |0 I:(DE-He78)L701-20160331
|k L701
|l DKTK München
|x 6
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)G110-20160331
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)B220-20160331
980 _ _ |a I:(DE-He78)G100-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)L701-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21